![]() |
市场调查报告书
商品编码
1290380
全球无抗生素肉类市场 - 2023-2030年Global Antibiotic-Free Meat Market - 2023-2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
全球无抗生素肉类市场在2022年达到1343亿美元,预计到2030年将见证有利可图的增长,达到2920亿美元。在2023-2030年的预测期内,市场预计将呈现10.2%的复合增长率。
抗生素在动物身上的使用已经得到了美国食品和药物管理局的授权。在过去的几年里,这种抗生素的使用量稳步增加,导致动物体内抗生素的病菌发展。在美国,根据FDA的评估,大约80%的抗生素只用于动物。农民有必要负责任地使用抗生素,以加速牲畜的生长。为了防止在不卫生的环境中饲养的动物发生疾病,需要抗菌素抗性。
农民喜欢对牲畜使用抗生素,这也导致了耐抗生素微生物的出现。耐药性微生物降低了人类的抗生素有效性。无抗生素肉市场的需求是消费者对无抗生素残留药物和无抗生素饲养的动物(RSW)无抗生素生产的认识提高的结果。
无抗生素肉的扩张的主要驱动力是消费者对含有合成化学品的食品的负面后果的认识不断提高。当人们吃那些动物的常规肉时,用于生产动物的化学品和杀虫剂会导致致命的疾病,包括人类的癌症。
由于顾客青睐无抗生素肉,认为它是传统牛肉产品的优越替代品。由于其昂贵的生产过程和农业方法,不使用抗生素的肉类生产成本大约是使用抗生素的肉类的两倍。由于可支配收入的增加带来了购买力的提高,无抗生素肉类市场在发展中国家的扩张获得了动力。
无抗生素牛肉市场的重要发展是新的研究和开发倡议。为了使他们的产品多样化,在无抗生素市场竞争的主要企业正在不断推进技术和商业实践,并通过开展疫苗接种计划,采取替代性疾病预防措施。
例如,美国餐饮公司和芝士蛋糕经销商The Cheesecake Factory将于2022年6月开始在牛肉和猪身上使用 "永远不使用抗生素 "的肉类。此外,2021年6月,美国大型快餐连锁店的控股公司Wendy's改变了其抗生素使用政策,承诺到2030年在美国和加拿大的牛肉、猪肉和家禽供应链中停止定期使用医学上必要的抗生素。
COVID-19分析包括前COVID情景、COVID情景和后COVID情景,以及定价动态(包括大流行期间和之后的定价变化与前COVID情景的比较)、需求-供应谱(由于贸易限制、封锁和后续问题造成的需求和供应变化)、政府倡议(政府机构振兴市场、部门或行业的倡议)和制造商战略倡议(这里将涉及制造商为缓解COVID问题所做的努力)。
The Global Antibiotic-Free Meat Market reached US$ 134.3 billion in 2022 and is projected to witness lucrative growth by reaching up to US$ 292 billion by 2030. The market is expected to exhibit a CAGR of 10.2% during the forecast period 2023-2030.
Antibiotic usage in animals has been authorized by the FDA. Over the past few years, this usage of antibiotics has steadily increased, leading to the development of germs that are resistant to them in animals. In the US, around 80% of antibiotics are only used on animals, according to an FDA assessment. Responsible use of antibiotics is necessary by farmers to hasten the growth of their livestock. Antimicrobial resistance is needed to prevent disease in animals kept in unhygienic circumstances.
Antimicrobial resistance is preferred by farmers to their livestock, which also causes the emergence of antibiotic-resistant microorganisms. Antibiotic effectiveness in humans is lowered by drug-resistant microorganisms. The antibiotic-free meat market demand is a result of consumers' increased awareness of antibiotic residue free drugs and antibiotic-free production by the animals raised without antibiotics (RSW).
The main driver of the expansion of meat without antibiotics is the growing consumer knowledge of the negative consequences of food containing synthetic chemicals. When people eat the conventional meat from those animals, the chemicals and pesticides used to produce the animals cause fatal illnesses including cancer in humans.
As the customers favour antibiotic-free meat as a superior alternative to conventional beef products. Due to its expensive production processes and agricultural methods, meat produced without the use of antibiotics costs approximately twice as much as meat produced with them. The expansion of antibiotic-free meat market in developing nations has gained momentum owing to the rise in purchasing power brought on by the rise in disposable income.
The important development in the market for antibiotic-free beef is new research and development initiatives. To diversify their product offerings, major businesses that compete in the antibiotic-free market are constantly advancing technology and business practises and adopting alternative disease prevention measures by conducting vaccination programs.
For instance, the U.S. restaurant company and cheesecake distributor The Cheesecake Factory will start using "No Antibiotics Ever" meat on beef and pig in June 2022. Additionally, in June 2021, Wendy's, an American holding company for the big fast food chain, changed its antibiotic usage policy, pledging to stop regularly using medically necessary antibiotics in its supply chains for beef, pork, and poultry in the U.S. and Canada by 2030.
The COVID-19 analysis includes Pre-COVID Scenario, COVID Scenario and Post-COVID Scenario along with pricing dynamics (including pricing change during and post-pandemic comparing it with pre-COVID scenarios), demand-supply spectrum (shift in demand and supply owing to trading restrictions, lockdown, and subsequent issues), government initiatives (initiatives to revive market, sector or industry by government bodies) and manufacturers strategic initiatives (what manufacturers did to mitigate the COVID issues will be covered here).
In the Global Market of Antibiotic-Free Meat, the Fresh Meat Segment Holds the Largest Market Share.
The global antibiotic-free meat market has been segmented by form into fresh antibiotic-free meat, processed antibiotic-free meat. The fresh antibiotic-free meat segment held the largest antibiotic-free meat market share of 52.3% in 2022 in the antibiotic-free meat market analysis report.
The antibiotic-free meat market demand over the past several years has been accelerated by the rising production and consumption of fresh meat products in developed and developing nations. Global meat consumption has climbed by 58% over the past 20 years, according to a research by the Organisation for Economic Co-operation and Development, as a result of population expansion and rising disposable income in developing nations.
In addition, it is anticipated that throughout the course of the forecast period, rising consumer demand for prebiotics in animal production, probiotics in animal production, and wholesome food products is estimated to drive the market expansion. Antibiotic-free meat market trends includes the growing global urbanization and cold chain growth, along with the rising consumption of fresh meat due to its many health benefits.
The global antibiotic-free meat market is segmented into five parts of the world based on geography: North America, South America, Europe, Asia Pacific, the Middle East, and Africa. The Asia-Pacific antibiotic-free meat market held the largest market share of 42.6% in 2022 in the antibiotic-free meat market analysis.
The growth in the region is obtained as a result of increased urbanization, westernization, the growth and expansion of the organic meat products business, changing lifestyles, and more personal disposable income. Rising farmer's knowledge of the withdrawl periods for antibiotics and health advantages of meat products devoid of antibiotics will open up profitable and rewarding market expansion prospects.
In 2019, the Indian government recommended banning the antibiotic "colistin," which is often used in the country's livestock and poultry industries. To address the problem of anti-microbial resistance, the regulatory action was taken to ensure the cautious use of anti-microbial agents in people and animals. Thus, it is anticipated that over the forecast period, the market for antibiotic-free meat in the region will increase as a result of rising concerns about food safety and the ensuing demand for high-quality meat.
The major global players in the market include: Cargill Inc., Tyson Foods, Inc., JBS S.A., Hormel Foods Corporation, American Foods Group, LLC, Koch Foods, Inc., Smithfield Foods, Inc., National Beef Packing Company, LLC, Perdue Farms Inc., and Allanasons Private Ltd.
The unprecedented COVID-19 pandemic in 2020 had a profound effect on the antibiotic-free industry. COVID-19 has had a considerable impact on the phases of the global meat supply chain that involve meat production, processing, distribution, and consumption as a result of lockdowns and restrictions imposed by various governments.
Additionally, meat processing and packaging facilities have been impacted by physical separation regulations and a labor shortage. Distribution of meat was greatly impacted by the transportation laws that were prohibited because of lockdowns. The distribution of meat and the supply chain were also impacted by the production of meat being limited.
The global antibiotic-free meat market report would provide approximately 93 tables, 109 figures and 190 pages.
LIST NOT EXHAUSTIVE